Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3B rAHF-PFM in previously untreated patients with hemophilia A
2004-001623-38Phase 3Completed
- Sponsor
- Baxter International Inc.
- Start
- Oct 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of recombinant coagulation factor viii in hemophilia A, sponsored by Baxter International Inc. Primary endpoints: Immunogenicity, Efficacy and 1 more. Started Oct 2004; status: completed.
02
Drugs
recombinant coagulation factor viii
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2004-001623-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001623-38.